Diagnosing HCC in the Setting of HBV

(2:56)

Diagnosing HCC in the Recurrent HCV Setting

(3:37)

The use of immunotherapy in HCC – In depth subgroup analyses and challenges

(4:21)

Diagnosing HCC in Chronic Liver Disease

(3:50)

Liver Transplant for HCC in the 21st Century

(26:22)

Optimal Management of HCC: Integrating Novel Therapeutic Approaches Across the Continuum of Care

(1:29:6)

Essential Conversations for HCC: Radiology-Oncology Collaboration and Immunotherapy Advances

(1:1:58)

How I Treat Advanced Hepatocellular Carcinoma: Mastering Immunotherapy for Optimal Outcomes

(31:1econd)

Incidence and Determinants of HCC in AIH

(4:40)

Novel treatments for HCC in the era of Hep C therapies

(34:37)

HCC Whiteboard #1: The Epidemiology of Hepatocellular Carcinoma and Current Standard of Care

(5:26)

MILR of HCC in cirrhosis

(15:)

Systemic Therapy for HCC in Africa - Ashraf Omar, MD

(16:24)

Dr. Finn on Finding a Biomarker for Patients With HCC

(2:9)

Prevention and Monitoring Strategies for HCC in HBV Patients - Wai-Kay Seto, MBBS, MD, MRCP, FRCP

(12:33)

Incidence and Determinants of HCC in AIH

(4:42)

Update: Novel treatments for HCC in the era of hepatitis C therapies

(21:58)

Evidence-Based Treatment Selection and Sequencing in Advanced HCC

(1:37:24)

Line Management of HCC in the Immunotherapy Era

(23:28)

Local ablation of HCC in the sub-Saharan context - Prof Eduard Jonas

(59:6)